Punit Dhillon
co-founder
Genetics
CRB
Spain
Biography
Punit Dhillon is the co-founder and CEO of a leading biopharmaceutical company based in the U.S. that develops advanced-stage immunotherapy to treat solid tumors. Punit served as Vice President of Finance and Operations at Inovio Pharmaceuticals, Inc., where he raised more than $160 million through multiple financings and several licensing transactions, including early stage deals with Merck and Wyeth. His management experience spans corporate finance, M&A integration, successful in-licensing of key intellectual property, strategy implementation, corporate transactions and collaborations with leading universities and key global opinion leaders. Punit is also the founder of BeCancerPositive.org, an online community for cancer patients. In 2013, he was recognized as one of the “Top 100” CEOs by PharmaVoice and “Most Admired CEO” by the San Diego Business Journal. In 2014, Punit was recognized as a finalist for Ernst & Young’s “Entrepreneur of the Year”.
Research Interest
Genetics
